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Abstract: Phytochemical investigation of the aerial parts of Euphorbia sikkimensis led to the isolation of one new diterpenoids, 
named sikkimenoid E (1), together with thirteen other known compounds (2–14). Their structures were established by means of  
spectroscopic methods. Compound 2 was identified to be a trinortriterpenoid, and derived for the first time from a natural source. In 
this paper we reveal for the first time its comprehensive spectral data and NMR spectral assignment. Compound 4 showed anti-
angiogenic activity with an IC50 value of 5.66 μM in a zebrafish model, and compounds 5 and 6 exhibited cytotoxicity toward A549 
cell line with IC50 values of 12.12 and 6.45 μM, respectively. 
Keywords: Euphorbia sikkimensis, ingenol, trinortriterpenoid, tocopherol derivatives, bioactivities 
Introduction 
Plants of the genus Euphorbia are well known for their 
chemical diversity of their isoprenoid constituents. Terpenoids 
with different core frameworks perform extensive activities, 
such as anti-proliferation, modulability of multidrug resistance,  
cytotoxic activity, antimicrobial and anti-inflammatory  
bioactivities.1 Also, the roots of Euphorbia sikkimensis Boiss 
have been used in traditional Chinese medicine, for the  
treatment of poisoning, malaria, rheumatism, and other  
disorders.2 Previous studies on this plant have resulted in the 
isolation of four jatropholane-type diterpenoids.3 Our  
continuing phytochemical investigation on the aerial parts of E.  
sikkimensis led to the isolation of a new diterpenoid, named 
sikkimenoid E (1), along with thirteen known compounds  
(2–14). Compound 2 was revealed as a trinortriterpenoid  
derived from the oxidation of 3S,24S,25-trihydroxytirucall-7-
ene, and until recently, only its mass spectrometry data had 
been reported.4 Other known compounds were identified as  
8-geranyloxypsolaren (3),5 (–)-bornyl ferulate (4),6  
isopimara-8(14),15-dien-3-one (5),7 10-hydroxydepressin (6),8 
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Figure 1.  The structures of compounds 1–14 
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cycloart-23E-ene-3β,25-diol (7),9 sericeol (8),10  
spiroinonotsuoxodiol (9),11 α-tocopherolquinone (10),12 
(2R,4aR,8aR)-3,4,4a,8a-tetrahydro-4a-hydroxy-2,6,7,8a-tetra-
methyl-2-(4,8,12-trimethyltridecyl)-2H-chromene-5,8-dione 
(11),13 α-tocopherol (12),14 5-methoxymethyl-7,8-
dimethyltocol (13),15 and peplusol (14).16 All isolated  
compounds were evaluated for their anti-angiogenic activities 
using a zebrafish model and also for their cytotoxic potential 
against human lung cancer cells A549. In this paper, we report 
the isolation, structure elucidation and biological activities of 
these compounds. 
 
Results and Discussion 
Compound 1 was obtained as an optically active colorless 
oil ([α]22D   ＋ 37.5) and the molecular formula was deduced to 
be C38H50O8 based on its HREIMS data (m/z 634.3518, calcd 
634.3506, [M]+), suggesting 14 degrees of unsaturation. The 
UV spectrum displayed maximum absorption at 266 nm, 
which indicated the presence of conjugated chromophores. 
The IR spectrum of 1 suggested characteristic bands of  
hydroxyl (3442 cm–1), carbonyl (1728 cm–1) and olefinic (1640 
cm–1) groups. Analysis of the NMR spectra of 1 (Table 1)  
suggested the presence of one ketone (δC 205.7), four oxygen-
bearing carbons (δC 86.0, 82.4, 77.0, and 66.1), three ester 
carbonyls (δC 172.6, 170.6, and 170.5), six pairs of double 
bonds, six methylenes (one oxygenated at δC 66.1) and seven 
methyls. Except for one ketone, six pairs of double bonds and 
three ester carbonyls, there should have been four rings in 1 to 
fit the 14 degrees of unsaturation. Comparison of the NMR 
spectra (Table 1) of 1 with those of 20-O-(2'E,4'E-
decadienoyl)-ingenol17 revealed that 1 has the typical signals 
of an ingenol skeleton, a common chemotype in genus  
Euphobia1. Further analysis of the 2D NMR of 1 (Figure 2) 
showed the 1H-1H COSY correlations of H-7/H-8/H-14/H-
13/H-12/H-11/Me-18 and HMBC correlations of H-1 with C-3, 
C-4, C-9 and Me-19; and of H-3 with C-2 and C-10; and of  
H-7 with C-5, C-6 and C-9; of H-12 with C-10 and C-15 also 
supported the existence of ingenol skeleton in 1. The  
differences between 1 and 20-O-(2'E,4'E-decadienoyl)-ingenol 
could be rationalized to the carbon signals corresponding to 
acid moiety. The EIMS fragment peaks at m/z 151 [C9H15CO]+, 
95 [C5H7CO]+, 354 [M – C9H15COOH – C5H7COOH]+, 294 
[M – C9H15COOH – C5H7COOH – CH3COOH]+ suggested the 
ester residues of compound 1 were 2,4-decadienoyloxy group, 
2,4-hexadienoyloxy group and acetoxy group. The HMBC 
(Figure 2) correlations of H-3 with C-1"', and of H-20 with  
C-1" demonstrated that the acetoxy and decadienoyloxy 
groups were located at C-3 and C-20, respectively. The proton 
signal of H-5 in 1 resonated at δ 5.45 (s), shifting downfield by 
1.74 ppm, suggested that the hexadienoyloxy group is located 
at C-5. The configurations of conjugated double bonds were 
elucidated by analysis of its ROESY spectrum, comparison of 
the chemical shifts, and the coupling patterns with those  
reported data. In compounds with Z,E-configuration the  
coupling constants are normally J2,3 = 11.3 Hz,18 while  
coupling constants of E,E or E,Z-configuration are normally 
J2,3 = 15.2 Hz.17 In the case of 1, J2',3' = 15.3 Hz, J2",3" = 15.2 
Hz, corresponding to a trans double bond between C-2' and  
C-3', and between C-2" and C-3". In addition, another  
difference between E,E and E,Z-configuration of conjugated 
double bonds was the chemical shifts of H-5, normally δH-5 of 
E,Z-configuration was about 5.90 ppm, while δH-5 of E,E-
configuration was about 6.20 ppm.17,18 Chemical shifts of 5' 
(δH 5.89) and 5" (δH 6.19) of 1 indicating that double bond 
between C-4' and C-5' was cis, and that of between C-4" and 
C-5" was trans, which was also support by the observed 
ROESY correlation of H-4' with H-5' (Figure 3). The observed 
ROESY correlations of H-8 with Me-17; of H-13 with H-14; 
of Me-16 with H-13 and H-14; of H-13 with Me-18 and of 
Me-18 with H-1 suggested that the stereochemistry of  
ingenane diterpenoid part in 1 was the same as ingenol-3,5,20-
triacetate, which was established by the single-crystal X-ray 













Figure 2.  Selected HMBC ( ) and 1H-1H COSY ( ) 
correlations of compounds 1 and 2 
Table 1. The NMR [150 (13C) and 600 (1H) MHz, CDCl3, δ in ppm, J in Hz] data of 1 
position δC δH position δC δH 
1 132.2 CH 6.07 (s) 20a 66.1 CH2 4.43 (d, 12.5) 
2 133.4 C  20b  4.23 (d, 12.5) 
3 82.4 CH 4.97 (s) 1' 170.5 C  
4 86.0 C  2' 117.3 CH 5.88 (d, 15.3) 
5 77.0 CH 5.45 (s) 3' 147.4 CH 7.34 (dd, 15.3, 9.7) 
6 135.7 C  4' 128.3 CH 6.17 (m) 
7 131.3 CH 6.20 (d, 4.2) 5' 143.1 CH 5.89 (m) 
8 43.6 CH 4.26 (m) 6' 20.9 CH3 1.94 (br s) 
9 205.7 C  1" 170.6 C  
10 71.9 C  2" 119.3 CH 5.97 (d, 15.2) 
11 38.5 CH 2.51 (m) 3" 141.8 CH 7.69 (dd, 15.2, 12.0) 
12α 31.1 CH2 2.27 (m) 4" 126.3 CH 6.13 (m) 
12β  1.74 (m) 5" 146.4 CH 6.19 (m) 
13 23.0 CH 0.69 (dd, 15.6, 8.4) 6" 33.0 CH2 2.14 (q, 6.9) 
14 22.9 CH 0.94 (m) 7" 28.3 CH2 1.40 (m) 
15 24.4 C  8" 31.4 CH2 1.27 (m) 
16 28.4 CH3 1.04 (s) 9" 22.5 CH2 1.28 (m) 
17 15.5 CH3 1.08 (s) 10" 14.0 CH3 0.87 (t, 6.8) 
18 17.1 CH3 0.98 (d, 7.1) 1'" 172.6 C  
19 15.6 CH3 1.75 (m) 2'" 21.2 CH3 2.09 (s) 
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decadienoyloyl)ingenol (Figure 1) and was given a trivial 
name sikkimenoid E. 
Compound 2, was obtained as a white powder, and showed 
a negative specific rotation ([α]25D   – 16.2). The IR spectrum 
showed absorption bands at 3434 and 1639 cm–1, revealing the 
existence of hydroxyl and olefinic groups. The 1H and 13C 
NMR data (Table 2) exhibited resonances for a trisubstituted 
double bond (δH 5.23, d, J = 3.1 Hz; δC 118.0, d and 145.6, s), 
an aldehyde group (δC 203.1, d), an oxygenated methine (δH 
3.22, dd, J = 11.4, 4.0 Hz; δC 79.2, d). Comparison of the 
NMR data of 2 with those of cornusalterin J suggested that 
they share the same lanostane skeleton.20 The differences 
could be rationalized to the changes of the side chain, of which 
the structural part from C-23 to C-27 in cornusalterin J was 
replaced by a methylene and an aldehyde group in 2. This 
deduction was confirmed by the 1H,1H-COSY correlation of 
H-22 with H-23 and HMBC correlations of both H-22 and  
H-23 with C-24, and of H-24 with C-22 (Figure 2). The  
observed ROESY correlations of H-3/H-5, H-5/Me-29,  
H-5/H-9, H-9/Me-18 and Me-18/H-20 indicated that H-3, H-5, 
H-9, Me-18, H-20 and Me-29 are cofacial and assigned to be 
α-oriented, the same with the cornusalterin J. In turn the  
cross-peaks of Me-19/Me-28, Me-30/H-17, H-17/Me-21  
indicated the β-oriention of H-17, Me-19, Me-21, Me-28 and 
Me-30. Thus, the structure of 2 was determined as shown. 
From a literature research, compound 2 was only recorded in 
one reference, which was derived from oxidation of 
3S,24S,25-trihydroxytirucall-7-ene.4 Therefore, this is first 
report of 2 found from a nature source and given a trivial name 
sikkimenoid F. 
All the compounds were tested for their cytotoxicity against 
the human lung cancer cells A549 by the MTT method, with 
5-FU used as a positive control (IC50 17.28 μM).21 Compounds 
5 and 6 exhibited cytotoxicity toward A549 cell line with IC50 
values of 12.12 and 6.45 μM, respectively. In addition, the  
anti-angiogenic activities of all compounds were further  
evaluated using a zebrafish model in terms of the inhibition of 
the growth of intersegmental vessels, using PTK787 as a  
positive control (IC50 0.23 μM).22 The results showed that  
intersegmental vessels of embryo treated with compound 4 
were significantly fewer than those of the control (0.2% 
DMSO in sterile salt water), and the reduction was dose  
dependent, and with an IC50 value of 5.66 μM. It’s the first 
time that the anti-angiogenic activity of compound 4 and the 




General Experimental Procedures. Optical rotations were 
measured on a JASCO P-1020 digital polarimeter. UV spectra 
were obtained using a Shimadzu UV-2401A spectrophotometer.
IR spectra were obtained on a Bruker Tenor 27 spectrometer 
with KBr pellets. 1D and 2D NMR spectra were recorded on 
Bruker AM-400, DRX-500 or AV Ⅲ-600 spectrometers with 
TMS used as an internal standard. ESIMS spectra were per-
formed on a Finnigan MAT 90 instrument, EI and HREI spec-
tra were recorded on a Waters AutoSpec Premier P776 instru-
ment. Column chromatography was performed on Sephadex 
LH-20 (GE Healthcare), silica gel (200-300 mesh, Qingdao 
Marine Chemical Ltd., Qingdao, China), RP-18 gel (LiChro-
prep, 40–63 μm; Merck, Darmstadt, Germany), and MCI gel 
CHP 20P (75–150 μm, Mitsubishi Chemical Corporation, To-
kyo, Japan). Semipreparative HPLC was performed on a 
Hewlett-Packard instrument (column: Zorbax SB-C18, 250 × 
9.4 mm; DAD detector). Fractions were monitored by TLC, 
visualized by heating silica gel plates sprayed with 15% 
H2SO4 in EtOH. 
 
Plant Material. The aerial parts of E. sikkimensis were  
collected from Gongbo Gyamda County of the Tibetan  
autonomous region of China in 2010, and identified by  
Professor Yong-Ping Yang. A voucher specimen (Yangyp-
20100936) has been deposited at the Herbarium of Kunming 
Institute of Botany, Chinese Academy of Sciences. 
 
Extraction and Isolation. The dried and powdered aerial 
parts of E. sikkimensis (11 kg) were extracted with 90% EtOH 
Table 2. The NMR [100 (13C) and 400 (1H) MHz, CDCl3, δ in ppm, J in Hz] data of 2 
position δC δH position δC δH 
1α 37.1 CH2 1.10 (td, 12.9, 3.8) 14 51.2 C  
1β  1.65 (m) 15α 33.8 CH2 1.47 (m) 
2α 27.0 CH2 1.56 (m) 15β  1.78 (m) 
2β  1.65 (m) 16α 28.4 CH2 1.24 (m) 
3 79.2 CH 3.22 (dd, 11.4, 4.0) 16β  1.92 (m) 
4 38.9 C  17 53.0 CH 1.48 (m) 
5 50.5 CH 1.28 (dd, 12.0, 5.6) 18 22.0 CH3 0.80 (s) 
6α 23.9 CH2 1.92 (m) 19 13.1 CH3 0.72 (s) 
6β  2.10 (m) 20 35.5 CH 1.44 (m) 
7 118.0 CH 5.23 (d, 3.1) 21 18.0 CH3 0.82 (d, 6.3) 
8 145.6 C  22 27.6 CH2 1.23 (m) 
9 48.8 CH 2.15 (m) 23 41.5 CH2 2.40 (m) 
10 34.9 C  24 203.1 CH 9.75 (br. s) 
11 18.4 CH2 1.49 (m) 28 27.6 CH3 0.95 (s) 
12α 33.7 CH2 1.42 (m) 29 14.7 CH3 0.83 (s) 
12β  1.63 (m) 30 27.2 CH3 0.94 (s) 
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Figure 3.  Key ROESY correlations of compounds 1 and 2 
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(3 × 40 L) for 24 h at room temperature and filtrated. The  
filtrate was concentrated and partitioned between H2O and 
EtOAc and then the EtOAc portion was decolorized on MCI 
gel CHP 20P (eluting with 95% EtOH). The residue (690 g) 
was chromatographed on silica gel (80–100 mesh), eluting 
with CHCl3-Me2CO (from 1:0 to 1:0.2), to derive fractions A–
C. Fraction A was purified over a Sephadex LH-20, eluted 
with CHCl3-MeOH (1:1) and then fractionated by RP-18 gel, 
eluted with MeOH-H2O (from 30% to 100%) to provide  
subfractions (A1–A6). These subfractions were repeatedly 
chromatographed on silica gel and Sephadex LH-20  
respectively to yield compounds 3 (3.1 mg), 4 (22.3 mg), 5 
(7.8 mg), 7 (5.3 mg), 11 (5.2 mg), 12 (20.0 mg), 13 (4.3 mg) 
and 14 (45.5 mg). Fraction C was chromatographed on RP-18 
gel, eluted with a gradient of MeOH-H2O to afford five  
subfractions (C1–C5). C2 was further chromatographed on 
silica gel and Sephadex LH-20, and then purified by  
semipreparative HPLC (MeOH-H2O, 70:30) to furnish 1 (2.6 
mg, tR = 36 min) and 6 (5.2 mg, tR = 45 min). Compounds 2 
(30.5 mg), 8 (12.7 mg), 9 (10.0 mg) and 10 (11.2 mg) were 
isolated from C3–C5 by repeatedly chromatographed on silica 
gel and Sephadex LH-20. 
 
Sikkimenoid E (1): colorless oil; [α]22D   ＋ 37.5 (c 0.20, 
MeOH); UV (MeOH) λmax (log ε) 266 (4.18), 204 (4.33) nm; 
IR (KBr) νmax 3442, 3425, 3398, 2957, 2928, 2871, 1728, 1640, 
1461, 1380, 1314, 1234, 1156, 1131, 1024, 988 cm–1; 1H and 
13C NMR data see Table 1; EIMS m/z 634 [M]+ (9), 522 (5), 
372 (5), 354 (14), 312 (23), 294 (29), 233 (53), 151 (100), 122 
(34), 95 (27), 81 (57); ESIMS m/z 657 [M + Na]+; HREIMS 
m/z 634.3518 ([M]+, calcd for C38H50O8, 634.3506). 
 
Sikkimenoid F (2): white powder; [α]25D   – 16.2 (c 0.33, 
MeOH); UV (MeOH) λmax (log ε) 205 (3.64) nm; IR (KBr) νmax 3434, 2951, 2931, 2881, 2716, 1724, 1639, 1464, 1384, 
1276, 1248, 1163, 1100, 1066, 1034, 986 cm–1; 1H and 13C 
NMR data see Table 2; EIMS m/z 400 ([M]+). 
 
Cytotoxicity Assay.21 Compounds 1–14 were tested for 
their cytotoxicity against human lung cancer cell line A549 by 
the MTT method, and 5-FU was used as a positive control. 
Briefly, 100 μL cell suspension (1 × 105 cells/mL) was seeded 
into 96-well microtiter plates and cultured for 24 h before the 
compound was added. Then, different concentrations of the 
compounds were added to the plates, the cells were cultivated 
for 48 h, and 10 μL of MTT (5 mg/mL) was added to each 
well. After 4 h, the culture medium was removed and the 
formazan crystal was completely dissolved with 150 μL 
DMSO to each well by vigorously shaking the plate. Finally, 
formazan absorbance was assessed by a BioRad microplate 
reader at 570 nm. 
 
Antiangiogenesis Assay.22 Stock solutions (20 mg/mL) of 
all samples were prepared by dissolving the test compounds in 
100% DMSO. These solutions were diluted in sterile salt  
water (5 mM NaCl, 0.17 mM KCl, 0.4 mM CaCl2, 0.16 mM 
MgSO4) to obtain final solutions of various concentrations in 
0.2% DMSO. Aliquots were placed into 24-well plates, and 
embryos (TG[VEGFR2:GRCFP]) at 24 hpf (hours postfertili-
zation) were also transferred randomly into the above wells. 
Control embryos were treated with the equivalent amount of 
DMSO solutions. All embryos were incubated at 28.5 °C.  
After 48 h treatment, the intersegmental vessels of embryos 
were visualized with green fluorescent protein labeling and 
endogenous alkaline phosphatase staining. The antiangiogenic 
activities of compounds were calculated from the inhibition 
ratio of anti-angiogenesis. 
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